Combined Inhibition of TGF- Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models

Author(s):
Sow, H.S.; Ren, J.; Camps, M.; Ossendorp, F.; Dijke, P. ten (0000-0002-2875-4723)
Published
2019
Publication type
Article / Letter to editor
anti-PD-L1 mAb 1LY364947 2mouse syngeneic tumor models 3
Date issued
2019-04-30
Language
English
Is part of
hdl
1887/120660
doi
10.3390/cells8040320